Janus kinase inhibitor treatment improved both subcutaneous and pulmonary sarcoidosis in a patient with glaucoma.

Liu, Bei; Yin, Hanlin; Yang, Shaoying; Lu, Liangjing

Liu, Bei; Yin, Hanlin; Yang, Shaoying; Lu, Liangjing.

Afiliación

Liu B; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yin H; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yang S; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Lu L; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Clin Exp Dermatol ; 47(10): 1868-1870, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35699682

Asunto(s)

Glaucoma; Inhibidores de las Cinasas Janus; Sarcoidosis Pulmonar; Corticoesteroides; Humanos; Inhibidores de las Cinasas Janus/uso terapéutico; Quinasas Janus; Pirroles; Sarcoidosis Pulmonar/complicaciones; Sarcoidosis Pulmonar/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glaucoma / Sarcoidosis Pulmonar / Inhibidores de las Cinasas Janus Límite: Humans Idioma: En Revista: Clin Exp Dermatol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google